Functional heartburnWord文件下载.docx
《Functional heartburnWord文件下载.docx》由会员分享,可在线阅读,更多相关《Functional heartburnWord文件下载.docx(20页珍藏版)》请在冰豆网上搜索。
Functionalheartburnhasmoreincommonwithfunctionaldyspepsiathanwithnon-erosiverefluxdisease
ESavarino1,DPohl2,PZentilin1,PDulbecco1,GSammito1,LSconfienza1,SVigneri3,GCamerini4,RTutuian2,VSavarino1
1DivisionofGastroenterology,DepartmentofInternalMedicine,UniversityofGenoa,Genoa,Italy
2DivisionofGastroenterologyandHepatology,DepartmentofInternalMedicine,UniversityHospitalZurich,Zurich,Switzerland
3DivisionofGastroenterology,DepartmentofInternalMedicine,UniversityofPalermo,Palermo,Italy
4DivisionofSurgery,DepartmentofInternalMedicine,UniversityofGenoa,Genoa,Italy
Correspondenceto:
CorrespondencetoDrESavarino,CattedradiGastroenterologia,Università
diGenova,VialeBenedettoXV,16100Genova,Italy;
edoardo.savarino@unige.it
Revisedversionreceived6April2009
Accepted16April2009
ABSTRACT
TOP
ABSTRACT
Methods
Results
Discussion
REFERENCES
Introduction:
Functionaldyspepsiaandnon-erosiverefluxdisease(NERD)areprevalentgastrointestinalconditionswithaccumulatingevidenceregardinganoverlapbetweenthetwo.Still,patientswithNERDrepresentaveryheterogeneousgroupandlimiteddataondyspepticsymptomsinvarioussubgroupsofNERDareavailable.
Aim:
ToevaluatetheprevalenceofdyspepticsymptomsinpatientswithNERDsubclassifiedbyusing24himpedance-pHmonitoring(MII-pH).
Methods:
Patientswithtypicalrefluxsymptomsandnormalendoscopyunderwentimpedance-pHmonitoringoffprotonpumpinhibitortreatment.Oesophagealacidexposuretime(AET),typeofacidandnon-acidrefluxepisodes,andsymptomassociationprobability(SAP)werecalculated.Avalidateddyspepsiaquestionnairewasusedtoquantifydyspepticsymptomspriortorefluxmonitoring.
Results:
Of200patientswithNERD(105female;
medianage,48years),81(41%)hadanabnormaloesophagealAET(NERDpH-POS),65(32%)hadnormaloesophagealAETandpositiveSAPforacidand/ornon-acidreflux(hypersensitiveoesophagus),and54(27%)hadnormaloesophagealAETandnegativeSAP(functionalheartburn).Patientswithfunctionalheartburnhadmorefrequent(p<
0.01)postprandialfullness,bloating,earlysatietyandnauseacomparedtopatientswithNERDpH-POSandhypersensitiveoesophagus.
Conclusion:
Theincreasedprevalenceofdyspepticsymptomsinpatientswithfunctionalheartburnreinforcestheconceptthatfunctionalgastrointestinaldisordersextendbeyondtheboundariessuggestedbytheanatomicallocationofsymptoms.Thisshouldberegardedasafurtherargumenttotestpatientswithsymptomsofgastro-oesophagealrefluxdiseaseinordertoseparatepatientswithfunctionalheartburnfrompatientswithNERDinwhomsymptomsareassociatedwithgastro-oesophagealreflux.
Gastro-oesophagealrefluxdisease(GORD)isoneofthemostcommonchronicgastrointestinaldiseasesinWesterncountries.12Recentstudiesdocumentedthatupto70%ofrefluxpatientshavetypicalrefluxsymptoms(ie,heartburnand/orregurgitation)intheabsenceofendoscopicallyvisibleoesophagealmucosalinjuries,makingnon-erosiverefluxdisease(NERD)themorecommonformofGORD.34TheNERDpatientgroupincorporatessubgroupswhichdiffersignificantlyintermsofpresentation,pathophysiologyandmanagement.PatientsexperiencingtypicalrefluxsymptomswithoutevidenceofoesophagitisonupperendoscopyareclassifiedonthebasisofoesophagealpHmonitoringresultsandsymptomassociationanalysisassufferingeitherfromNERD,whenexcessiveacidrefluxorapositivesymptomassociationwithacidrefluxisdemonstrated,orfromfunctionalheartburn(FH),when,inagreementwithRomeIIIcriteria,distaloesophagealacidexposureisnormalandanegativeresponsetoacidsuppressionisfound.56Recognisingthatstimuliotherthanacidcanevoketypicalrefluxsymptoms,7ourgrouppreviouslyproposedsubclassifyingpatientswithtypicalrefluxsymptomsandnormaluppergastrointestinalendoscopyasfollows:
(1)NERDpH-POSpatientswithnormalendoscopyandabnormaldistaloesophagealacidexposure;
(2)hypersensitiveoesophagus–patientswithnormalendoscopy,normaldistaloesophagealacidexposureandpositivesymptomassociationforeitheracidornon-acidreflux;
and(3)functionalheartburn–patientswithnormalendoscopy,normaldistaloesophagealacidexposureandnegativesymptomassociationforacidandnon-acidreflux.8
PatientswithGORD,bothwitherosiveoesophagitisandNERD,frequentlyreportdyspepticsymptoms.9EpidemiologicalstudiesinvestigatingtheprevalenceofdyspepticandoesophagealsymptomshavereportedahigherprevalenceofdyspepticsymptomsinpatientswithGORD,suggestingthatthedegreeofoverlapisgreaterthancouldbepredictedbychancealone.10Moreover,itwasrecentlydemonstratedthatpatientswithfunctionalheartburnandpoorresponsetoacidsuppressivetherapyaremorelikelytohavepsychopathologysimilarlytopatientswithfunctionaldyspepsia.11Last,butnotleast,abdominalsymptomsappeartobeindependentpredictorsoftheseverityofrefluxsymptomsinpatientswithNERDwhencomparedtonormalcontrols.12
GivenpreviousreportsindicatinganinverserelationshipbetweendyspepticsymptomsandtheobjectivecriteriaforGORDwehypothesisedthatinpatientswithfunctionalheartburndyspepticsymptomsshouldbemoreprevalentcomparedtotherestofNERDpatients.Totestthishypothesis,weevaluatedtheprevalenceofdyspepticsymptomsinpatientswithNERDsubclassifiedintothreedistinctgroupsbyusing24hMII-pHmonitoring.
Methods
Studysubjects
BetweenJune2004andSeptember2008,patientspresentingtotheoutpatientmotilitycentreattheUniversityofGenoawithpredominanttypicalGORDsymptoms(ie,heartburnandregurgitation)lastingformorethan6monthsandoccurringatleastthreetimesweekly,wereprospectivelyenrolledinthestudy.Allsubjectswhoagreedtoparticipateinourinvestigationunderwentcarefulhistorytakingphysicalandclinicalexamination,uppergastrointestinalendoscopytoassessthepresenceornotofoesophagealmucosalinjury,routinebiochemistry,andupperabdominalultrasound.Themedicalhistoryincludedinformationontreatmentwithacidsuppressivemedication(inparticularprotonpumpinhibitors(PPIs))andsymptomaticresponsetoPPItherapy.Patientsreporting
50%symptomimprovementwereconsideredresponderstoPPItherapy.Patientstreatedwithantisecretorydrugswereaskedtodiscontinueacidsuppressivetherapyatleast30daysbeforetheendoscopicexamination.Duringthewashoutperiod,patientswereallowedtouseanoralantacidoralginateonanas-neededbasisforthereliefofheartburn.Basedontheresultsofupperendoscopy,patientswerethensubdividedintothreemajorgroups–Barrett’soesophagus,erosiveoesophagitisandNERD–incaseswherethetypicalsymptomsofGORDwerepresent,andwherevisibleoesophagealmucosalinjurywasabsent.PatientswithBarrett’soesophagusanderosiveoesophagitiswerenotincludedinthepresentstudy.Within1–5days(median3days)fromtheupperendoscopy,patientswithNERDunderwentambulatorycombinedimpedance-pHmonitoring.Exclusioncriteriawere:
historyofthoracic,oesophagealorgastricsurgery;
primaryorsecondarysevereoesophagealmotilitydisorders(eg,achalasia,scleroderma,diabetesmellitus,autonomicorperipheralneuropathy,myopathy);
underlyingpsychiatricillness;
useofnon-steroidalanti-inflammatorydrugs(NSAIDs)andaspirin;
presenceofpepticstrictureandduodenalorgastriculceronupperendoscopy,evidenceoferosiveoesophagitisatprevious(2–5years)endoscopy,presenceofdyspepticsymptomsasmajorsymptoms.Inwomenofchildbearingage,pregnancywasexcludedbyurineanalysis.Duringuppergastrointestinalendoscopy,biopsiesweretakenfromtheantrumandthecorpusforassessingthepresenceofHelicobacterpylori.Patientswereaskedtodiscontinueanymedicationthatwouldinfluenceoesophagealmotorfunctionatleast1weekbeforeadministeringthequestionnairesandperformingtestsofoesophagealfunction.
Allparticipantsgavewritteninformedconsentbeforeenteringthestudy.
Symptomquestionnaire
Beforethe24hpH-impedancestudy,eachpatientcompletedafunctionaldyspepsiaquestionnaireasreportedandvalidatedpreviously.13Thisquestionnaireincludedquestionsonthepresenceandintensity(range,0–3;
where0=absent,1=mild,2=moderate,and3=severe,interferingwithdailyactivities)ofepigastricpain,bloating,postprandialfullness,earlysatiety,nausea,vomiting,excessivebelchingandepigastricburning.Also,typicalGORDsymptoms(ie,heartburnandregurgitation)wereevaluatedusingthesamequestionnaire(0=absent,1=mild,2=moderate,and3=severe).Asecondinvestigatorcompletedastructuredinterviewwiththepatientincludingacarefulmedicalhistory(includingheightandweight),currentmedication,tobaccouseandalcoholconsumption.
OesophagealmultichannelintraluminalimpedanceandpHmonitoring
Oesophagealimpedance-pHmonitoringwasperformedusinganambulatorymultichannelintraluminalimpedanceandpH(MII-pH)monitoringsystem(Sleuth;
SandhillScientific,HighlandRanch,Colorado,USA).ThesystemincludedaportabledataloggerandacatheterwithoneantimonypHelectrodeandeightimpedanceelectrodesat2,4,6,8,10,14,16and18cmfromthetipofthecatheter.Eachpairofadjacentelectrodesrepresentedanimpedance-measuringsegment(2cmlength)correspondingtoonerecordingchannel.ThesiximpedanceandonepHsignalswererecordedat50Hzona128MB